Case-Based Roundtables on TargetedOnc.com are collaborative, small-group discussions about case-based clinical profiles and engaging peer-dialogue led by an expert physician. These resources offer practicing oncologists and hematologists insight on relevant data, treatment strategies, and varying professional opinions.

LATEST RENAL CELL CARCINOMA CONTENT

Considering the Role of Tivozanib After Prior ICI-Based Therapy in RCC

How Disease Burden Shapes First-Line RCC Treatment Selection

Risk, Histology, and Metastatic Site Guide First-Line RCC Treatment Choices

Navigating the Next Step After Progression in ccRCC

Treatment Goals Guide First-Line Choices in Metastatic RCC

Experts Debate PD-1 Rechallenge After ICI Progression in RCC

Optimizing Second-Line Therapy in Metastatic ccRCC

Choosing Among Frontline IO/TKI Regimens in Advanced RCC

CASE-BASED ROUNDTABLES

Using Immunotherapy Combinations in Multiple Lines of RCC Treatment

February 21, 2024

Sequencing for Metastatic Clear Cell Renal Cell Carcinoma After Prior Therapy

September 16, 2022

Experts Discuss the RCC Landscape and Available Therapy for Patients

September 13, 2022

Treating Renal Cell Carcinoma With Tyrosine Kinase Inhibition

First-Line Treatment Using Combination Therapy in Advanced RCC

December 20, 2021